Department of Psychiatry, The University of Iowa, Iowa City, USA.
Am J Med Genet B Neuropsychiatr Genet. 2011 Jul;156B(5):593-9. doi: 10.1002/ajmg.b.31200. Epub 2011 May 11.
Major depression (MD) is often associated with disturbances of the hypothalamic/pituitary/thyroid (HPT) axis. Unfortunately, whether this association is secondary to common underlying genetic variation or whether the MD-associated disturbances in HPT function are chronic or state-dependent is unknown. To examine these questions, we genotyped 12 single nucleotide polymorphisms identified in previous genome wide association analyses of thyroid function in DNA contributed by 1,555 subjects from three longitudinal ethnically diverse studies that are well-characterized for lifetime MD and thyroid function. We then examined associations between genetic variants and key outcomes of thyroid stimulating hormone, free thyroxine (FT4) and depression. We confirmed prior findings that two variants in deiodinase 1 (DIO1), including a variant in the 3'UTR of DIO1 (rs11206244), were associated with altered FT4 levels in both White and African American subjects. We also found that rs11206244 genotype was associated with lifetime MD in White female subjects, in particular those from high-risk cohorts. However, we found no association of current FT4 levels with lifetime MD in either ethnic group. We conclude that genetic variation influencing thyroid function is a risk factor for MD. Given the evidence from prior studies, further investigations of role of HPT variation in etiology and treatment of MD are indicated.
重度抑郁症(MD)常与下丘脑/垂体/甲状腺(HPT)轴功能紊乱相关。遗憾的是,这种相关性是由常见的潜在遗传变异引起的,还是与 MD 相关的 HPT 功能紊乱是慢性的或与状态相关的,目前尚不清楚。为了研究这些问题,我们对来自三个纵向、种族多样化的研究中 1555 名受试者的 DNA 进行了 12 个单核苷酸多态性的基因分型,这些研究对终生 MD 和甲状腺功能进行了全基因组关联分析。然后,我们检查了遗传变异与促甲状腺激素、游离甲状腺素(FT4)和抑郁的关键结果之间的关联。我们证实了先前的发现,即脱碘酶 1(DIO1)中的两个变异体,包括 DIO1 的 3'UTR 中的变异体(rs11206244),与白人和非裔美国人受试者的 FT4 水平改变相关。我们还发现,rs11206244 基因型与白种女性受试者的终生 MD 相关,尤其是来自高危队列的女性。然而,我们在两个种族群体中均未发现当前 FT4 水平与终生 MD 之间存在关联。我们得出结论,影响甲状腺功能的遗传变异是 MD 的一个风险因素。鉴于先前研究的证据,进一步研究 HPT 变异在 MD 的病因和治疗中的作用是必要的。